Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Generalized Seizures Global Clinical Trials Review, H2, 2014


News provided by

ReportBuyer

Jul 23, 2014, 01:17 ET

Share this article

Share toX

Share this article

Share toX

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Generalized Seizures Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2243626/Generalized-Seizures-Global-Clinical-Trials-Review-H2-2014.html

Generalized Seizures Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Generalized Seizures Global Clinical Trials Review, H2, 2014" provides data on the Generalized Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Generalized Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Generalized Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Introduction 6
Generalized Seizures 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Generalized Seizures to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Generalized Seizures to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Generalized Seizures 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Generalized Seizures Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
UCB S.A. 32
Clinical Trial Overview of UCB S.A. 32
Johnson & Johnson 34
Clinical Trial Overview of Johnson & Johnson 34
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Eisai Co., Ltd. 37
Clinical Trial Overview of Eisai Co., Ltd. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Mylan Inc. 39
Clinical Trial Overview of Mylan Inc. 39
Dr. Reddy's Laboratories Limited 40
Clinical Trial Overview of Dr. Reddy's Laboratories Limited 40
Desitin Arzneimittel GmbH 41
Clinical Trial Overview of Desitin Arzneimittel GmbH 41
Boehringer Ingelheim Auslandsbeteiligungs GmbH 42
Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 42
Clinical Trial Overview of Top Institutes / Government 43
National Institute of Neurological Disorders and Stroke 43
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 43
University Hospital Freiburg 44
Clinical Trial Overview of University Hospital Freiburg 44
Capital District Health Authority, Canada 45
Clinical Trial Overview of Capital District Health Authority, Canada 45
Emory University 46
Clinical Trial Overview of Emory University 46
Hadassah Medical Organization 47
Clinical Trial Overview of Hadassah Medical Organization 47
Massachusetts General Hospital 48
Clinical Trial Overview of Massachusetts General Hospital 48
U.S. Department of Veterans Affairs 49
Clinical Trial Overview of U.S. Department of Veterans Affairs 49
Maastricht University Medical Center 50
Clinical Trial Overview of Maastricht University Medical Center 50
Assistance Publique - Hopitaux de Paris 51
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 51
Gillette Children's Specialty Healthcare 52
Clinical Trial Overview of Gillette Children's Specialty Healthcare 52
Five Key Clinical Profiles 53
Appendix 119
Abbreviations 119
Definitions 119
Research Methodology 120
Secondary Research 120
About GlobalData 121
Contact Us 121
Disclaimer 121
Source 121


List of Tables

Generalized Seizures Therapeutics, Global, Clinical Trials by Region, 2014* 7
Generalized Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Generalized Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Generalized Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Generalized Seizures Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Generalized Seizures Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Generalized Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Generalized Seizures Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Generalized Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Generalized Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Generalized Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Generalized Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Generalized Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Generalized Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Generalized Seizures Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Generalized Seizures Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Generalized Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Generalized Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Generalized Seizures Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Generalized Seizures Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Generalized Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Generalized Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Generalized Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Generalized Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Generalized Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 32
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 34
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 35
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 36
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 37
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2014* 39
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2014* 40
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Desitin Arzneimittel GmbH, 2014* 41
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014* 42
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 43
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2014* 44
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2014* 45
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 46
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 47
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 48
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 49
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 50
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 51
Generalized Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Gillette Children's Specialty Healthcare, 2014* 52


List of Figures

Generalized Seizures Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Generalized Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Generalized Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Generalized Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Generalized Seizures Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Generalized Seizures Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Generalized Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Generalized Seizures Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Generalized Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Generalized Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Generalized Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Generalized Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Generalized Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Generalized Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Generalized Seizures Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Generalized Seizures Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Generalized Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Generalized Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Generalized Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Generalized Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Generalized Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Generalized Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Generalized Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 120


Read the full report:
Generalized Seizures Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2243626/Generalized-Seizures-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.